Head and neck radiotherapy is a continuously evolving field. The disease itself has changed with the increase in human papilloma virus (HPV) associated oropharyngeal cancer. With this new disease entity, oncologists are struggling to determine optimal therapy. As radiation oncologists, we are questioning our traditional use of chemotherapy as well as our radiation doses and volumes.
|Original language||English (US)|
|Title of host publication||Medical Radiology|
|Number of pages||21|
|State||Published - 2020|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging